tiprankstipranks
Trending News
More News >
Invex Therapeutics Ltd. (AU:IXC)
ASX:IXC
Australian Market

Invex Therapeutics Ltd. (IXC) Revenue

Compare
2 Followers

Invex Therapeutics Ltd. Revenue

Invex Therapeutics Ltd. had a revenue of 0.00 in the quarter ending Dec 31, 2024, with -100.00%. This bring the company's revenue in the last twelve months to 1.21M, Decreased 0.00%. In the fiscal year ending Jun 30, 2024, Invex Therapeutics Ltd. had annual revenue of 1.21M with 164.06% growth.
Revenue (ttm)
1.21M
Revenue Growth
P/S Ratio
5.02
Revenue/Employee
Employees
Market Cap
AU$6.09M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Jun 30, 2024
1.21M753.17K+164.06%
Jun 30, 2023
459.08K276.83K+151.90%
Jun 30, 2022
182.25K+∞%
Jun 30, 2021
0.00
Jun 30, 2020
0.00
Jun 30, 2019
0.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis